Financial News
All News about Incyte Corp
![](https://www.investors.com/wp-content/uploads/2018/09/stock-Incyte-01-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/05/02/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230502005266/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230501005479/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Incyte
May 01, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
What 13 Analyst Ratings Have To Say About Incyte
March 28, 2023
Via Benzinga
![](https://www.investors.com/wp-content/uploads/2019/07/stock-Incyte-02-shutter.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/21/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230420005667/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://mms.businesswire.com/media/20230418005078/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230416005053/en/1762530/22/MorphoSys_Logo.jpg)
![](https://www.investors.com/wp-content/uploads/2023/04/TECH1_mifepristone_041423_newscom.jpg)
![](https://mms.businesswire.com/media/20230411005060/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://www.investors.com/wp-content/uploads/2022/06/Stock-microntechnology-folsom-01-company.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/10/biotech_shutter.jpg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/04/10/valero_energy_-_logo.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20230326005073/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/24/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230323005785/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
From Incyte
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/03/23/incy.png?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230322005618/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://investorplace.com/wp-content/uploads/2022/07/healthcare-1600.jpg)
![](https://mms.businesswire.com/media/20230318005041/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://mms.businesswire.com/media/20230318005040/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
![](https://g.foolcdn.com/editorial/images/724890/dna-genetic-sequencing-biotech-1.jpg)
![](https://mms.businesswire.com/media/20230314006043/en/1078784/22/Incyte_Color_Logo_JPEG_%282_Color_Positive%29.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.